OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Antirheumatic Drugs against COVID-19 from the Perspective of Rheumatologists
Mai Kawazoe, Mari Kihara, Toshihiro Nanki
Pharmaceuticals (2021) Vol. 14, Iss. 12, pp. 1256-1256
Open Access | Times Cited: 13
Mai Kawazoe, Mari Kihara, Toshihiro Nanki
Pharmaceuticals (2021) Vol. 14, Iss. 12, pp. 1256-1256
Open Access | Times Cited: 13
Showing 13 citing articles:
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper
Thomas Marjot, Christiane S. Eberhardt, Tobias Boettler, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 4, pp. 1161-1197
Open Access | Times Cited: 62
Thomas Marjot, Christiane S. Eberhardt, Tobias Boettler, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 4, pp. 1161-1197
Open Access | Times Cited: 62
The evolution of the global COVID-19 epidemic in Morocco and understanding the different therapeutic approaches of chitosan in the control of the pandemic
Youssef Ait Hamdan, Fatima El Amerany, Jacques Desbrières, et al.
Polymer Bulletin (2022) Vol. 80, Iss. 10, pp. 10633-10659
Open Access | Times Cited: 12
Youssef Ait Hamdan, Fatima El Amerany, Jacques Desbrières, et al.
Polymer Bulletin (2022) Vol. 80, Iss. 10, pp. 10633-10659
Open Access | Times Cited: 12
Comprehensive multi-omics analysis elucidates colchicine-induced toxicity mechanisms and unveils the therapeutic potential of MLN4924 and kinase inhibitors
Linhui Zhai, Xinglong Jia, Yu-Lu Chen, et al.
Acta Pharmacologica Sinica (2024)
Closed Access | Times Cited: 2
Linhui Zhai, Xinglong Jia, Yu-Lu Chen, et al.
Acta Pharmacologica Sinica (2024)
Closed Access | Times Cited: 2
Immunosuppressant Therapies in COVID-19: Is the TNF Axis an Alternative?
Yadira Palacios, Leslie Chávez‐Galán
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 616-616
Open Access | Times Cited: 11
Yadira Palacios, Leslie Chávez‐Galán
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 616-616
Open Access | Times Cited: 11
Pacritinib Inhibition of IRAK1 Blocks Aberrant TLR8 Signalling by SARS-CoV-2 and HIV-1-Derived RNA
Grant R. Campbell, Pratima Rawat, Stephen A. Spector
Journal of Innate Immunity (2022) Vol. 15, Iss. 1, pp. 96-106
Open Access | Times Cited: 10
Grant R. Campbell, Pratima Rawat, Stephen A. Spector
Journal of Innate Immunity (2022) Vol. 15, Iss. 1, pp. 96-106
Open Access | Times Cited: 10
Infliximab as a potential treatment for COVID-19
Matthew P. Velez, Matthew W. McCarthy
Expert Review of Anti-infective Therapy (2022) Vol. 21, Iss. 1, pp. 1-5
Closed Access | Times Cited: 8
Matthew P. Velez, Matthew W. McCarthy
Expert Review of Anti-infective Therapy (2022) Vol. 21, Iss. 1, pp. 1-5
Closed Access | Times Cited: 8
Optimizing the use of vilobelimab for the treatment of COVID-19
Matthew W. McCarthy
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 9, pp. 877-881
Closed Access | Times Cited: 4
Matthew W. McCarthy
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 9, pp. 877-881
Closed Access | Times Cited: 4
Immunomodulatory mechanisms of abatacept: A therapeutic strategy for COVID-19
Dinglong Yang, Hetong Li, Yujing Chen, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 3
Dinglong Yang, Hetong Li, Yujing Chen, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 3
COVID-19 presentation and outcomes in patients with inflammatory rheumatic and musculoskeletal diseases receiving IL6-receptor antagonists prior to SARS-CoV-2 infection
Cloé Comarmond, Élodie Drumez, Julien Labreuche, et al.
Journal of Translational Autoimmunity (2023) Vol. 6, pp. 100190-100190
Open Access | Times Cited: 1
Cloé Comarmond, Élodie Drumez, Julien Labreuche, et al.
Journal of Translational Autoimmunity (2023) Vol. 6, pp. 100190-100190
Open Access | Times Cited: 1
Determinators of clinical outcomes in patients with chronic arthritis and systemic connective tissue disorders: COVID-19 pandemic focus
Irena Pušica, Mirjana Lapčević, Stojanka Ratković, et al.
Opsta medicina (2024) Vol. 30, Iss. 1-2, pp. 29-40
Open Access
Irena Pušica, Mirjana Lapčević, Stojanka Ratković, et al.
Opsta medicina (2024) Vol. 30, Iss. 1-2, pp. 29-40
Open Access
Transport of glycinin, the major soybean allergen, across intestinal epithelial IPEC‐J2 cell monolayers
Shugui Zheng, Yintong Zhao, Ziang Zheng, et al.
Journal of Animal Physiology and Animal Nutrition (2024) Vol. 108, Iss. 5, pp. 1360-1369
Closed Access
Shugui Zheng, Yintong Zhao, Ziang Zheng, et al.
Journal of Animal Physiology and Animal Nutrition (2024) Vol. 108, Iss. 5, pp. 1360-1369
Closed Access
S1-Leitlinie zur Versorgung von Lebertransplantierten während der COVID-19-Pandemie – AWMF-Registernummer: 021-031 – Stand 15. Juni 2022
Frank Tacke, Markus Cornberg, Martina Sterneck, et al.
Zeitschrift für Gastroenterologie (2022) Vol. 60, Iss. 11, pp. 1678-1698
Closed Access | Times Cited: 2
Frank Tacke, Markus Cornberg, Martina Sterneck, et al.
Zeitschrift für Gastroenterologie (2022) Vol. 60, Iss. 11, pp. 1678-1698
Closed Access | Times Cited: 2
Therapie von COVID-19 unter Berücksichtigung von Lebererkrankungen
Markus Cornberg, Christopher Dietz-Fricke
Deleted Journal (2023) Vol. 18, Iss. 2, pp. 122-135
Open Access
Markus Cornberg, Christopher Dietz-Fricke
Deleted Journal (2023) Vol. 18, Iss. 2, pp. 122-135
Open Access
